Naringenin ameliorates PCOS-associated miscarriage by targeting C/EBPβ to suppress decidual macrophage pyroptosis
To determine whether naringenin ameliorates PCOS-associated miscarriage by targeting C/EBPβ-dependent decidual macrophage pyroptosis. Methods: DHEA-induced PCOS mice and an in vitro macrophage pyroptosis model were used. Transcriptomic profiling, PELSA-based target identification, molecular docking, molecular dynamics simulations, ChIP-qPCR, and gain-/loss-of-function experiments were performed. Results: Naringenin reduced embryo resorption and restored decidual homeostasis in PCOS mice. Transcriptomics identified macrophage pyroptosis via NLRP3/AIM2–caspase-1–GSDMD activation as a key pathological feature of PCOS decidua, which naringenin attenuated in vivo and in vitro. PELSA combined with structural validation identified C/EBPβ as a molecular target of naringenin. Pharmacological C/EBPβ inhibition attenuated pyroptosis, whereas C/EBPβ overexpression diminished naringenin's protection. Mechanistically, naringenin reduced C/EBPβ occupancy at Aim2, IL18, and IL1β promoters, suppressing inflammasome transcriptional activation. Naringenin ameliorates PCOS-associated miscarriage by targeting C/EBPβ, thereby suppressing inflammasome activation and decidual macrophage pyroptosis.
Authors
- Hongying Kuang (ORCID: https://orcid.org/0009-0005-2682-2007)
- Shuang Ma
- Chang Sun
- Xianzhuo Cheng
- Chunyang Guo
- Jingtong Meng
- Qingxia Song
- Xinyuan Mu
Institutions
- Nanjing University of Chinese Medicine (CN)
- Heilongjiang University of Chinese Medicine (CN)
- First Affiliated Hospital of Heilongjiang University of Chinese Medicine (CN)
- Suzhou Traditional Chinese Medicine Hospital (CN)
Publication Details
- Journal
- iScience
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1016/j.isci.2026.118205
- Primary Topic
- Inflammasome and immune disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00